COBB STUART (Chief Scientific Officer) received a stock award from NEUROGENE INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/28/2025ACC: 0001404644-25-000025
Officer· Chief Scientific Officer
Since Feb 2026
+50.10K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
50.10K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+7.20K
Price / share
—
Trade value
—
% of position
35.3%
3/26/2025
20.39K→27.59K
Total
Net shares
+7.20K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/26/2025 | A · Award | +7.20K | — | — | 35.3% | 20.39K | 27.59K |
| Total | +7.20K | $0.00 | ||||||
Derivative Transactions1
Employee Stock Option (Right to buy)
Direct
Converts to
Common Stock
42.90K shares
Shares
+42.90K
Strike price
16.14
Held after
42.90K
Exercisable
—
3/26/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to buy) Direct | Common Stock42.90K shares | 3/26/2025 | A · Award | +42.90K | 16.14 | — | 42.90K |